People In Brief
This article was originally published in The Gray Sheet
Executive Summary
OrbusNeich adds sales experience: Genous Bio-engineered R-Stent maker appoints Massimo Chiesa and Per Arne Winberg to its expanding sales and marketing team July 30. Chiesa, who has worked for EuroCor International, Volcano Therapeutics, Jomed and SCIMed (now part of Boston Scientific), is now OrbusNeich's director for Western Europe, the Middle East and Latin America. Winberg brings sales experience from Abbott Vascular, Jomed and Johnson & Johnson/Cordis and becomes director for Northern and Eastern Europe. Antibody-coated Genous was CE-marked in 2005. OrbusNeich touts the device as a safer alternative to drug-eluting stents and is seeking entry into the U.S. market (1"The Gray Sheet" May 28, 2007, p. 5)...